Peer-reviewedCC BY 4.0iScience
In situ-activated engineered bacteria release combined dual-therapeutic proteins for tumor immunotherapy
Related
- 951 Engineered tumor-homing bacteria enable systemic combination immune checkpoint blockade and cytokine immunotherapy
- Engineered bacteria-mediated stromal remodeling in pancreatic ductal adenocarcinoma: therapeutic opportunities and translational limits-a narrative review.
- Sense-and-respond: Engineered bacteria drive epithelial repair during gut inflammation
- Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer
- CCR7+ activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity
BibTeX
@article{wang2026situactivated,
title = {{In situ-activated engineered bacteria release combined dual-therapeutic proteins for tumor immunotherapy}},
author = {Xin-Ge Wang and Yue-Lan Huang and Xuan-Ren Shi and Zhen-Ping Zou and Ying Zhou and Bang-Ce Ye},
journal = {iScience},
year = {2026},
month = nov,
doi = {10.1016/j.isci.2026.118090},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03473-5},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - In situ-activated engineered bacteria release combined dual-therapeutic proteins for tumor immunotherapy
AU - Xin-Ge Wang
AU - Yue-Lan Huang
AU - Xuan-Ren Shi
AU - Zhen-Ping Zou
AU - Ying Zhou
AU - Bang-Ce Ye
PY - 2026
DA - 2026/11/01
JO - iScience
DO - 10.1016/j.isci.2026.118090
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03473-5
SN - 2589-0042
ER -